New phase 3b data on Lilly's Taltz and Zepbound advance understanding of the interconnected immune and metabolic biology in adults with psoriasis and obesity: Indianapolis Saturda ...

At THE WEEK Metabolic Health Summit 2026 in Uttar Pradesh, leading medical experts, researchers, and government officials ...

It was over a year ago, on September 1, that 42-year-old Arielle (not her real name) started taking weight loss medication. Before starting her treatment, ...

The World Health Organization (WHO) has released its first guidelines on the growing problem of obesity in children and ...

Over the last three decades, differences in unhealthy cholesterol levels and blood pressure between older adults with obesity ...

Barbados is set to launch a $1.2bn debt-for-social swap by January 1, unlocking more than $320m in savings to fund healthcare programmes and tackle childhood obesity, Finance Minister Ryan Straughn ...

While the adult obesity rate appears to be slowing in the United States, childhood obesity remains historically high, ...

Children older than 10 can be prescribed weight loss jabs and similar drugs if changing lifestyle does not work, the first global guidelines on childhood obesit ...

The global GLP-1 drugs market is entering a new phase of expansion as demand shifts beyond traditional diabetes treatment ...

The FDA flagged a potential safety signal after four patient deaths in a trial testing a schizophrenia drug, Argenx faces an unusual setback, and more pharma news.

Hour Detroit Top Doc Suki Singh, M.D. of Henry Ford Health discusses the evolution of the obesity medicine specialty.

Eli Lilly and Company (NYSE: LLY) today announced new exploratory data from the TOGETHER-PsO Phase 3b clinical trial evaluating the ...